COVID-19 vaccine trial resumes at UW

AstraZeneca’s COVID-19 vaccine trial is resuming at UW Health and the UW School of Medicine and Public Health, according to a Wisconsin State Journal report. The trial was put on hold in early September after a participant in the UK became ill with transverse myelitis, a spinal inflammatory disorder.

An independent safety review board has completed reviewing the case and concluded the trial can resume.